© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Behin Barahimi, MD, discusses some current trends in the treatment of dry eye disease. An oculoplastic, orbital and reconstructive sur
It's a new day at Oklahoma, which is starting anew with Brent Venables at head coach after an active offseason that saw Lincoln Riley and a few starters leaving the program.
But the Sooners are still working from a firm foundation with Venables emerging as the most respected defensi
It's a new day at Oklahoma, which is starting anew with Brent Venables at head coach after an active offseason that saw Lincoln Riley and a few starters leaving the program.
But the Sooners are still working from a firm foundation with Venables emerging as the most respected defensi
Editor's note: This is the latest story in the "#SWFLstrong" series, profiling individuals making a positive difference in the community. These articles will be featured on a regular basis in the Collier Citizen, Marco Eagle and The Banner.
Instruments filled the small room. A phoro
Editor's note: This is the latest story in the "#SWFLstrong" series, profiling individuals making a positive difference in the community. These articles will be featured on a regular basis in the Collier Citizen, Marco Eagle and The Banner.
Instruments filled the small room. A phoro
© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
LBS-008 is the company’s orally administered tablet for the treatment of Stargardt disease. There are currently no FDA approved trea
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
Twitter is starting a new test that allows users to post images, videos and GIFs in one multimedia tweet. Until now, users could post only one form of media per tweet. But this new format will shake things up and let people combine multiple formats in one tweet.
The company confirmed the
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
Open